Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Receivables (2016 - 2025)

Avricore Health has reported Receivables over the past 12 years, most recently at $279058.4 for Q4 2025.

  • Quarterly Receivables rose 2803.53% to $279058.4 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $279058.4 through Dec 2025, up 2803.53% year-over-year, with the annual reading at $278527.3 for FY2025, 2740.28% up from the prior year.
  • Receivables was $279058.4 for Q4 2025 at Avricore Health, down from $289809.7 in the prior quarter.
  • Over five years, Receivables peaked at $414555.8 in Q2 2023 and troughed at -$490066.6 in Q4 2022.
  • The 5-year median for Receivables is $17356.9 (2024), against an average of $58792.7.
  • Year-over-year, Receivables plummeted 6837.72% in 2021 and then skyrocketed 4115.51% in 2023.
  • A 5-year view of Receivables shows it stood at -$57055.9 in 2021, then plummeted by 758.92% to -$490066.6 in 2022, then surged by 151.68% to $253253.9 in 2023, then crashed by 96.2% to $9611.0 in 2024, then surged by 2803.53% to $279058.4 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Receivables are $279058.4 (Q4 2025), $289809.7 (Q3 2025), and $272839.8 (Q2 2025).